AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 18.0% in March

AngioDynamics, Inc. (NASDAQ:ANGO) was the recipient of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 1,784,550 shares, a drop of 18.0% from the February 26th total of 2,176,310 shares. Based on an average daily volume of 282,420 shares, the short-interest ratio is presently 6.3 days. Currently, 4.6% of the company’s shares are short sold.

AngioDynamics Price Performance

Shares of AngioDynamics stock opened at $10.90 on Monday. The stock has a market capitalization of $449.30 million, a price-to-earnings ratio of -16.27 and a beta of 0.48. The business has a 50-day moving average of $10.80 and a 200 day moving average of $11.54. AngioDynamics has a 12 month low of $8.36 and a 12 month high of $13.99.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ANGO. Zacks Research upgraded shares of AngioDynamics from a “hold” rating to a “strong-buy” rating in a report on Friday, January 9th. Wall Street Zen downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating in a report on Sunday, December 21st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AngioDynamics in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in ANGO. State of Alaska Department of Revenue acquired a new position in shares of AngioDynamics in the third quarter valued at approximately $25,000. Farther Finance Advisors LLC increased its stake in AngioDynamics by 146.4% during the 4th quarter. Farther Finance Advisors LLC now owns 2,018 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 1,199 shares during the period. Washington Trust Advisors Inc. acquired a new stake in AngioDynamics during the 3rd quarter worth approximately $27,000. Kemnay Advisory Services Inc. acquired a new stake in AngioDynamics during the 4th quarter worth approximately $27,000. Finally, State of Wyoming purchased a new position in AngioDynamics in the 2nd quarter valued at approximately $31,000. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Company Profile

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company’s products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.